Navin Fluorine International LtdNSE:NAVINFLUOR
Current view Q4 2026
Specialty chemical maker: sales up 41%, profit doubled as new plants filled up, with more capacity landing next year. Management reliably delivers. Only catch is the very expensive share price.
Latest exchange filings last 5 · 5 after Q4 2026
- 16 Sep ’26Niche99 ESG assigned Navin Fluorine a 64.54 Performer rating on September 15, 2026. ↗
- 9 Sep ’26Newspaper advertisement regarding opening of the Special Window for transfer and dematerialisation (demat) of physical shares. ↗
- 7 Sep ’26Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 7 Sep ↗
- 7 Sep ’26Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 7 Sep ↗
- 26 Aug ’26Allotment of Equity Shares under Employees'' Stock Option Scheme 2017 ↗
Exchange filings, with the company's own one-line summary, read off the same page as the figures. Screener publishes only the most recent few, so this is the last 5 — not everything filed since your note, and a quiet-looking list is not proof of a quiet quarter. A filing is marked new when it is dated after the end of the quarter your note covers. Not scored, and not a judgement — a routine repayment notice and a takeover sit in the same list.
AI concall report · Q4 2026
The full earnings-call read behind this view — what management promised, what they delivered, and the earning trigger.
Growth Q4 2026
| Metric | This year vs lastYoY · vs Q4 2025 | vs the quarter beforeQoQ, sequential · vs Q3 2026 | 3-year yearly average3Y CAGR · compounded | 5-year yearly average5Y CAGR · compounded |
|---|---|---|---|---|
| Sales | ▲ +33.8% | +5.2% | +16.9% | +23.0% |
| Operating profit | ▲ +79.3% | +4.2% | +24.8% | +23.1% |
| EPS | ▲ +116.6% | +14.7% | +19.6% | +20.0% |
| PAT | ▲ +124.2% | +15.1% | — | — |
Tinted rows drive the Tier. Tier = the weaker of YoY Sales and YoY PAT growth. Here the weaker is Sales at +33.8%, which is ≥ 20% → Tier 1.
QoQ is sequential, not a trend. For most Indian companies the March quarter is seasonally the largest, so a June-quarter fall against it is a calendar effect. Only the YoY column feeds the Tier.
Multibagger potential
Good69/100
⚠ Your own view on this company is Concern. Read the note above first — this score reads the figures, and it has not read the concall.
Growing fast — and the market has noticed. Profit per share grew 20% a year, and buyers now pay more for each rupee of it than they did a year ago. Some of the re-pricing has already happened.
₹8,433 → ₹16,865 needs the P/E at 76× — it is 65× today, and has ranged 57× to 118× over the last 5 years. The rest would come from earnings growing as they have.
What you pay for its profitlog scale · 5-year range
Tripling needs 114× — it has traded there — high was 118×.
At ₹9,833 the price-tag on its earnings reaches the 76× it is being projected toward — the point where being cheap against that yardstick is used up.
Both engines fired — but you're buying after the re-rate.
How this is calculated
This is arithmetic, not a forecast — Return = ΔEPS × ΔMultiple. It says what would have to be true, not how likely it is, and "earnings keep growing at this rate for three more years" is the assumption doing the most work. This is a large-cap at ₹41,629 cr, so the odds of a re-rate are not fighting its own size.
Growth rate used: 19.6% — the weakest of EPS / Sales / Op-profit from 3-year EPS CAGR. Latest quarter reads 60%.
How it compares with its rivals Chemicals · 6 of 94 listed
It earns 21% on its capital, second of 6, and it is the fourth most expensive of the 6 shown.
| Company | Price | P/E | Size | ROCE | Profitlast qtr | Saleslast qtr |
|---|---|---|---|---|---|---|
| Navin Fluo.Intl. | ₹8,429 | 54.5× | ₹43,252 Cr | 21.0% | +107.7% | +44.1% |
| Pidilite Inds. | ₹1,595 | 61.3× | ₹1.62 L Cr | 31.0% | +28.2% | +21.3% |
| Gujarat Fluoroch | ₹4,577 | 81.4× | ₹50,278 Cr | 9.6% | +21.4% | +24.0% |
| Deepak Nitrite | ₹1,605 | 27.6× | ₹21,892 Cr | 11.4% | +207.5% | +36.4% |
| Aether Industri. | ₹1,639 | 90.7× | ₹21,754 Cr | 11.9% | +28.0% | +27.3% |
| Atul | ₹6,142 | 22.7× | ₹18,082 Cr | 14.9% | +92.0% | +25.0% |
Screener's own peer group, from the request already made for the industry P/E. It serves the industry's largest names by market cap, not companies of a similar size, so treat this as context rather than a like-for-like table; this company is always shown. On a phone the price, size and sales columns are dropped rather than pushed off the edge. Not part of the score.
Business quality to Jun 2026
| Are the margins widening? | yes — widening, and steadily | operating margin 23% → 34% over 3 years |
|---|---|---|
| Did the profit turn into cash? | more than all of it — reserves released cash too | 97% last year, 138% over three · free cash flow ₹404 cr, positive in 3 of 5 years |
| Is the growth borrowed? | lightly borrowed | ₹1,272 cr — 0.32× its own equity (was 0.56×) |
| Is it being collected? | collection is steady | 83 days to collect, down 7 in a year · cash cycle 60 days |
| Who has been buying? | the promoters have held steady | promoters 27.1% (−0.9 in a year), 28.8% → 27.1% over 2.8 years · FIIs 23.7% (+2.2) · DIIs 28.5% (−0.2) · shareholders 1,47,191 → 1,38,594 |
| What does it earn on its capital? | earns a high return on the capital it employs | ROCE 21.0% · ROE 19.6% |
Fetched from the filings, not typed — and deliberately not part of the score. These are the questions the score cannot ask: it reads growth, price and trend, so a company can score well while its profit never becomes cash. Weigh these beside the note, not against the number.
Screener's own checklist not mine, not the score
In its favour
- Company is expected to give good quarter
- Company has delivered good profit growth of 21.4% CAGR over last 5 years
Against it
- Stock is trading at 10.8 times its book value
Generated by screener.in from a fixed checklist — not written by me and not an input to the score. It is here as a second machine opinion to weigh against the note; where it disagrees with the view above, the note is the considered one.